|
AKT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78073999999029E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.89379999998773E-06 |
| Normal-vs-Stage2 |
1.551590E-02 |
| Normal-vs-Stage3 |
2.453900E-02 |
| Normal-vs-Stage4 |
6.183900E-03 |
| Stage1-vs-Stage2 |
9.725400E-01 |
| Stage1-vs-Stage3 |
8.391800E-02 |
| Stage1-vs-Stage4 |
4.291800E-01 |
| Stage2-vs-Stage3 |
3.187000E-01 |
| Stage2-vs-Stage4 |
6.454600E-01 |
| Stage3-vs-Stage4 |
5.006400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.966400E-04 |
| Normal-vs-AfricanAmerican |
1.613380E-04 |
| Normal-vs-Asian |
5.04720000238379E-08 |
| Caucasian-vs-AfricanAmerican |
9.724500E-03 |
| Caucasian-vs-Asian |
1.519270E-03 |
| AfricanAmerican-vs-Asian |
4.712800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.03940000000392E-05 |
| Normal-vs-Female |
8.06970000000184E-05 |
| Male-vs-Female |
3.274200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.03110000000151E-05 |
| Normal-vs-Age(41-60Yrs) |
3.594400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.977500E-03 |
| Normal-vs-Age(81-100Yrs) |
6.652000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.053200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.647200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.364200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.045400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.825000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.928000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.895000E-03 |
| Classical-VS-Follicular |
1.297050E-01 |
| Classical-VS-Other |
7.091200E-01 |
| Classical-VS-Normal |
3.54719999999809E-05 |
| Tall-VS-Follicular |
2.023400E-03 |
| Tall-VS-Other |
2.496800E-01 |
| Tall-VS-Normal |
4.033400E-01 |
| Follicular-VS-Other |
8.221800E-01 |
| Follicular-VS-Normal |
1.193420E-04 |
| Other-VS-Normal |
1.579650E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.5190999999889E-06 |
| Normal-vs-N1 |
3.040000E-02 |
| N0-vs-N1 |
1.091610E-01 |
|
|
